Efficacy and Tolerability of MK0533 in Patients With Type 2 Diabetes (0533-005)
Efficacy and Tolerability of MK0533 in Patients With Type 2 Diabetes (0533-005)
A study to evaluate the effectiveness and tolerability of MK0533 and pioglitazone in patients
 with type 2 diabetes mellitus.
Inclusion Criteria:

 -  Patients between the ages of 18 to 70 years with Type 2 diabetes who have not been
 able to adequately control their blood glucose levels

 -  Note: Only patients who have not been taking any antihyperglycemic medicine for 3
 months will be screened

 Exclusion Criteria:

 -  Patients taking any medicines that affect body fluid level such as a diuretic or water
 pill

 -  Patients taking niacin or other certain medications

 -  Patients with any of the following conditions: liver or kidney disease, poorly
 controlled high blood pressure, heart disease or certain blood disorders

 -  Patients with abnormal laboratory results from a blood test that will be given before
 each patient starts the study